Selcia Doubles Its Radiolabeling Labs

By Michael McCoy

Department: Business
Keywords: API, radiolabeling, carbon 14

Business Concentrates

U.S. Firms Detail Investments
Coca-Cola Advances BioBased Bottles
Italian Firms Get Dow’s XLA Business
Polysilicon Makers Shrink Capacity
Shell To Scale Up Diphenyl Carbonate
Air Products Invests In China
GM And Teijin Link For Carbon Fibers
Mascoma And Valero Plan Ethanol Plant
AstraZeneca Acquires Chinese Generics Firm
Selcia Doubles Its Radiolabeling Labs
PCI Expands With Biogen Idec Pact
Prestwick In Alliance With Pharma Plexus
Janssen Signs Deal With Pharmacyclics
Business Roundup
All Concentrates

[+]Enlarge

Credit: Selcia

Selcia has doubled its capacity to conduct carbon 14 radiolabeling projects at its facility in Ongar, Essex, England. The company says it has been preparing radiolabeled active pharmaceutical ingredients for customers with compounds in Phase I clinical trials following certification by British authorities in September 2010.

Credit: Selcia

Selcia has doubled its capacity to conduct carbon-14 radiolabeling projects in Ongar, Essex, England. The company says it has been preparing radiolabeled active pharmaceutical ingredients for customers with compounds in Phase I clinical trials since September 2010, after certification by British authorities. Drug companies create radiolabeled versions of developmental compounds for metabolism, mass-balance, and microtracer studies, Selcia notes.

Topics

MAGAZINE

COLLECTIONS

VIDEOS

JOBS